Novartis eliminerà la differenza di prezzo tra gli Stati Uniti e altri paesi industrializzati e vedrà paesi al di fuori degli Stati Uniti come responsabili del consumo di una quota più elevata del costo per l’innovazione.

    Il CEO VAS Narasimhan ha descritto i prezzi degli Swiss Drug come “troppo bassi”, affermando che sono all’estremità inferiore rispetto alla media dell’OCSE.

    Fonte: https://www.perplexity.ai/page/novartis-chef-will-schweizer-m-1hxkxn3ot0wsbrcq_unqow

    https://i.redd.it/qrj678rvtjqf1.jpeg

    di GagaMiya

    Share.

    15 commenti

    1. Cortana_CH on

      Look at this smile. That‘s the look when you know you‘ll earn a couple more millions per year.

    2. General_Guisan on

      UBS Bankers: We’re the most criminal scumbags in Switzerland

      Vas Narasimhan: Hold my Mango Lassi

    3. Novartis taxes are “much too low” they are at the lower end compared to the OECD average.

    4. deejeycris on

      Did someone do the calculations? Because as far as I know, meds cost less in neighbouring countries like Germany, am I mistaken?

    5. NeighborhoodLoud4884 on

      Shareholder value must be protected at all cost. Reducing prices in the us? No, best we can do is rising prices everywhere else

    6. Kickbanblock on

      Let me translate this:
      “Highly overpaid CEO who sells highly overpriced medicaments everywhere in the world tries to use the current political environment in the US to justify even higher prices.”

    7. Old-Conversation2646 on

      Pharmacy is the shadiest inustry ever.

      I HATE people making profit out of people in need of medicine. People WILL PAY when they suffer. Therefore it is very immoral….

      The fact, that nearly ALL medicine is in need of annual replacement or “will expire”. A product that is 100% artificial can somehow expire?? what a mafia

    8. Ill_Campaign3271 on

      That’s not how drug prices work. Most of them have to be negotiated between the companies and the government

    9. gamblingPharmaStocks on

      The reason this happens is the US “most favored nation” policy. Pharmaceutical companies are not in the position of strongarming the US, as they are currently their primary customer.

      Unless there is some countermeasure at European level, this is inevitable.

    10. Suspicious_Ad6382 on

      Dawm every day they try more and more to push people for a revolution

    11. GarlicThread on

      Why are we letting American nationals become CEOs of major Swiss companies and raise prices on Swiss people to extract more wealth from our economy?

    12. Gumphant on

      I hope the Bundesrat and „Preisüberwachung“ will have to say something here.

    Leave A Reply